AXS - AXIS Capital Holdings Limited
Axis Capital (AXS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AXSM advances AXS-12 toward potential approval after the FDA accepts its NDA for cataplexy in narcolepsy and sets a May 2027 decision date.
FDA sets PDUFA target action date of May 1, 2027 NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for AXS-12 (reboxetine) for the treatment of cataplexy in narcolepsy. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of May 1, 2027.
PEMBROKE, Bermuda, July 06, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results for the second quarter ended June 30, 2026 on Tuesday, July 28, 2026 after the close of the financial markets. Vince Tizzio, President and Chief Executive Officer, and Matthew Kirk, Chief Financial Officer, will host an investor teleconference, including a question and answer period, on Wednesday, July 29, 2026 at 8:30 a.m.
Axis Capital (AXS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AXIS Capital's specialty insurance strength, premium growth and underwriting profitability support growth, while currency exposure and economic uncertainty remain concerns.
PEMBROKE, Bermuda, June 15, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital” or “AXIS” or the “Company”) (NYSE: AXS) today announced that it has appointed Pradip Patiath to the Company's Board of Directors. Effective June 15, 2026, Mr. Patiath will join the Board, where he will serve on its Risk and Human Capital and Compensation Committees.
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
AXIS Capital targets growth in specialty insurance and reinsurance while boosting investment income and shareholder returns.
PEMBROKE, Bermuda, May 13, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited ("AXIS Capital" or the “Company”) (NYSE: AXS) today announced that its Board of Directors has declared a quarterly dividend of $0.44 per common share payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AXIS Capital Holdings common stock remains unappealing due to persistent underperformance versus peers and modest forward growth expectations. AXS.PR.E preferred shares offer a 6.99% yield, are investment grade, and appear undervalued relative to both company debt and sector peers. Strong dividend coverage, stable capital structure, and recent $300M share repurchase authorization enhance preferred dividend safety and investor confidence.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AXS beats Q1 estimates as underwriting income climbs and premiums grow, offsetting weaker investment income and higher expenses.
AXIS Capital Holdings Limited (AXS) Q1 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Axis Capital (AXS) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Axis Capital (AXS) came out with quarterly earnings of $3.42 per share, beating the Zacks Consensus Estimate of $3.23 per share. This compares to earnings of $3.17 per share a year ago.
For the first quarter of 2026 , the Company reports:
For the first quarter of 2026, the Company reports: Annualized return on average common equity ("ROACE") of 17. 0% and annualized operating ROACE of 17. 7% Combined ratio of 89. 8% Underwriting income of $187 million, an increase of $24 million, or 15%, compared to the first quarter of 2025 Book value per diluted common share of $78.